Vesugen (KED)
7 indexed publications · 0 human studies · research from 2010 to 2021
Research goals studied
- Delivery & pharmacokinetics
- Gene & DNA regulation
- Immune function
- Longevity & aging
- Neuro & cognition
Studies referencing Vesugen (KED)
Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease
2021 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Peptide Regulation of Gene Expression: A Systematic Review
2021 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Peptide Regulation of Cell Differentiation
2020 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer's Disease
2017 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Tetrapeptide KEDW Interacts with DNA and Regulates Gene Expression
2015 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Effect of Tripeptide Lys-Glu-Asp on Physiological Activity of Neuroimmunoendocrine System Cells
2012 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Study of Biological Activity of Lys-Glu-Asp-Trp-NH2 Endogenous Tetrapeptide
2010 · Preclinical
Title-level bibliographic record. Consult the primary article before interpreting outcomes, methods, sample size, or safety.
Working with Vesugen (KED)?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free